A Common Hospital Antiseptic May Be Fueling Antibiotic Resistance, Study Finds

A widely used antiseptic in hospital settings, designed to eliminate harmful microorganisms, may inadvertently be fostering the development of antibiotic-resistant bacteria. New research published in the journal Environmental Science & Technology reveals that residual amounts of common antiseptics, such as chlorhexidine, can linger on hospital surfaces for extended periods, creating environments where bacteria can adapt and potentially evolve resistance to critical antibiotics. This discovery adds a new layer of complexity to the global challenge of antimicrobial resistance (AMR), highlighting how seemingly innocuous cleaning agents could be contributing to a growing public health crisis.
The study, led by Dr. Erica Hartmann, a professor of civil and environmental engineering at Northwestern University’s McCormick School of Engineering, investigated the presence and impact of chlorhexidine residues in an intensive care unit (ICU). Chlorhexidine is a potent disinfectant frequently applied to patients’ skin before surgical procedures or the insertion of medical devices like catheters, aiming to prevent infections. However, the research suggests that even after cleaning protocols, trace amounts of this antiseptic can persist on surfaces, creating a subtle but significant environmental pressure on resident bacteria.
The Subtle Threat of Antiseptic Residues
Bacteria possess a remarkable ability to adapt to their surroundings, and exposure to even low, non-lethal concentrations of antimicrobial agents can trigger evolutionary responses. The study differentiates between "tolerance" and "resistance." Bacterial tolerance means that the microorganisms can survive certain concentrations of a chemical more easily than their counterparts, though they can still be eradicated by standard antiseptic doses. Antimicrobial resistance, on the other hand, is a more alarming development, where bacteria can proliferate even when exposed to concentrations of an antiseptic that would typically prove lethal.
The research posits that as bacteria adapt to tolerate faint traces of antiseptics, they may engage in genetic exchange, swapping segments of DNA. Crucially, the same DNA that confers tolerance to antiseptics might also provide cross-protection against antibiotics, the very drugs designed to combat bacterial infections. This mechanism of gene transfer is a well-established pathway for the spread of antimicrobial resistance, and its potential linkage to antiseptic use is a significant concern for public health.
Investigating the ICU Environment
To understand the prevalence of this phenomenon, Hartmann and her team collected 219 environmental samples from various surfaces within an Illinois medical center’s ICU in 2018. These surfaces included bedrails, nurse call buttons, door sills, keyboards, light switches, and sink drains, spanning six distinct areas within the unit. Despite the rooms appearing to be meticulously clean, the researchers successfully isolated approximately 1,400 bacterial strains. Alarmingly, a substantial 36% of these isolates exhibited some degree of tolerance to chlorhexidine.
Further laboratory experiments demonstrated the persistence of chlorhexidine on common hospital materials such as plastic, metal, and laminate. Even after cleaning with water and other chemical agents, traces of the antiseptic remained detectable on these surfaces for at least 24 hours. While these lingering residues were not potent enough to kill bacteria outright, they created microenvironments where bacteria were continuously exposed to sub-lethal doses of a powerful antimicrobial.

The study highlighted that bacteria harboring genes that confer tolerance to these chemicals are more likely to survive and outcompete those lacking such genetic advantages. This selective pressure can lead to a gradual increase in the prevalence of tolerant bacteria within the hospital environment. In the most concerning scenario, this prolonged exposure could facilitate the evolution of true resistance, rendering the antiseptic less effective.
The Sink as a Hotspot
A particularly significant finding of the study was the identification of hospital sinks as a "hotspot" for antiseptic-tolerant bacteria. Sinks, with their consistently humid and warm U-bends, provide an ideal breeding ground for microbial life. Furthermore, the constant flow of water can wash diluted chemicals down the drain, creating a continuous low-level exposure environment that fosters adaptation.
Beyond their role as reservoirs, sinks are also implicated in the airborne transmission of bacteria. As water flows from the tap, strikes standing water, or splashes against the drain, it can generate aerosols – tiny particles that can remain suspended in the air. The researchers’ sampling data, which found tolerant strains on door sills, suggests that these airborne bacteria can travel throughout the ICU environment and settle on different surfaces. This airborne dispersal mechanism is a critical factor in the widespread presence of tolerant bacteria, even in areas where the antiseptic is not directly applied.
Cross-Resistance: A Double-Edged Sword
Perhaps the most concerning aspect of the research is the potential for cross-resistance. Some of the chlorhexidine-tolerant bacteria identified in the study carried plasmids – small, circular DNA molecules that can be easily transferred between bacteria, even across different species. These plasmids not only facilitated tolerance to chlorhexidine but also carried genes that could confer resistance to critical antibiotics, including carbapenems, which are often considered last-resort treatments for serious bacterial infections.
Dr. Danna Gifford, a lecturer in antimicrobial resistance at the University of Manchester, who was not involved in the study, commented on the significance of this finding. She emphasized that this mechanism of gene transfer is a well-documented route for the spread of antimicrobial resistance. The implication that antibiotic resistance could be accelerated "without the use of antibiotics," driven solely by antiseptic exposure, is a stark warning.
Reassessing Antiseptic Use: Balancing Efficacy and Risk
Despite these findings, the researchers and external experts are careful to note that chlorhexidine remains a highly effective antiseptic when used appropriately. The bacteria exhibiting tolerance in the study could only survive very low concentrations of the chemical, significantly below the levels typically employed for patient care.

"I don’t think that this supports a really conservative approach" to using chlorhexidine, stated Dr. Gifford. She cautioned that restricting the use of essential disinfectants in high-risk areas like ICUs, without robust clinical evidence, could inadvertently increase the risk of infections for vulnerable patients.
However, this research, alongside other recent studies, does raise pertinent questions about the judicious use of antiseptics. Dr. Hartmann suggested that further investigations are warranted to determine if these observed effects extend to other environments, such as homes and veterinary clinics. In many household settings, simpler cleaning methods like soap and water are often sufficient for maintaining hygiene, and a reduction in antiseptic use in these contexts could be considered.
The Broader Implications for the Antimicrobial Resistance Crisis
The growing challenge of antimicrobial resistance is a global health emergency, threatening to return medicine to a pre-antibiotic era where common infections could be fatal. The World Health Organization (WHO) has repeatedly warned that AMR is one of the biggest threats to global health, food security, and development today. It is estimated that by 2050, AMR could cause 10 million deaths annually, surpassing deaths from cancer.
"We are running out of antibiotics that work effectively," Dr. Hartmann stated, underscoring the urgency of the situation. "We are not quite fully there yet, but if we don’t intervene in the things that we do now, we’re going to end up in a situation in the future where we can’t do simple things like treat dental infections or do surgery because we can’t then give patients antibiotics after treatment."
The findings of this study contribute to a broader understanding of the multifactorial nature of AMR. It highlights that the problem is not solely confined to the overuse or misuse of antibiotics in human medicine and agriculture, but also encompasses the unintended consequences of other antimicrobial chemicals used in various environments. A comprehensive strategy to combat AMR must therefore encompass not only responsible antibiotic stewardship but also a critical evaluation of the use of all antimicrobial agents, including antiseptics.
The research team’s recommendation for future studies to explore the impact of antiseptic residues in diverse settings is crucial for developing evidence-based guidelines. Understanding the full spectrum of how these chemicals interact with microbial communities in different environments will be key to mitigating their potential contribution to the escalating crisis of antimicrobial resistance. Ultimately, a multi-pronged approach involving responsible use, environmental monitoring, and ongoing research is essential to preserve the efficacy of our vital antimicrobial arsenal.
The study, "Hospital environments harbor Chlorhexidine-Tolerant bacteria potentially linked to chlorhexidine persistence in the environment," was published in Environmental Science & Technology on April 2, 2026, with the DOI: https://doi.org/10.1021/acs.est.5c18587. The research was supported by grants from the National Institute of Allergy and Infectious Diseases.
This article is for informational purposes only and is not meant to offer medical advice.







